Thank you for subscribing!
Finfeed Archived Apr 06, 2021
Creso Pharma (ASX: CPH) has appointed a US Director of Business Development just as New York State has legalised recreational cannabis. New York State is expected to become one of the largest recreational markets in the US valued at US$4.2BN.
Finfeed Archived Mar 19, 2021
Creso Pharma Limited (ASX:CPH, FRA:1X8) has announced three new purchase orders for its wholly-owned Canadian subsidiary, Mernova Medicinal Inc, with a total value of C$177,122.40 (A$183,019.55).
Finfeed Archived Mar 09, 2021
Today, Creso Pharma Limited (ASX:CPH, FRA:1X8) announced a Letter of Interest (LOI) which marks its entry into the CBD market for sport and recreation; an industry whose global valuation is estimated at US$22Bn by 2022 and C$220m in Canada alone.
Finfeed Archived Feb 17, 2021
Creso Pharma Limited (ASX:CPH, FRA:1X8) has announced that its wholly-owned Canadian subsidiary Mernova Medicinal Inc. has secured four purchase orders (“PO”) for its leading Ritual Green product range, with a total value of C$494,131 (A$502,199).
Get expert stock analysis direct in your inbox
Finfeed Archived May 27, 2020
Here to speak with Finfeed today about the ups and downs of the cannabis industry, cannabis in Canada and what he sees is the future of the cannabis industry is COO and director of Embark Health, Mike Curtis.
Finfeed Archived Apr 28, 2020
Canada’s WeedMD is pivoting to help the broader health sector as COVID-19 continues to put lives in danger.
Finfeed Archived Apr 16, 2020
MMJ Group Holdings Limited (ASX: MMJ/OTC: MMJJF) has agreed to provide a C$2.5 million secured convertible note facility to Sequoya Cannabis Limited.
Next Investors Archived Apr 09, 2020
MMJ Group (ASX: MMJ) scours the globe evaluating the best opportunities in cannabis and is quietly amassing positions at discounted prices right now, as the sector is considered out of favour.
Finfeed Archived Mar 17, 2020
Will cannabis stocks survive the Coronavirus? The strong will survive and there could be bargains to be had.
Join Our Mailing List